Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

McMaster University

$43,000.00

Microsystems for drug discovery and biological studies

EF 2011-12

Résumé
Microfabricated Lab-on-Chip devices for genomics and proteomics have been widely researched and developed over the past decade and have gained significant acceptance among biological and biomedical researchers. The next grand challenge is the miniaturization of laboratory automation technologies for handling and manipulating living biological cells, embryos and small organisms that would enable faster analysis, lower cost, greater precision and parallelization (high throughput) over existing methods. These devices are essential in many biological studies and procedures such as embryology, in-vitro fertilization, transgenics, stem cell engineering/ transformation and in toxicology. They are also critically important in the drug discovery process where increasingly, small model organisms such as Zebrafish and C.elegans are being used for determining potent drug candidates from millions of molecules in the chemical compound libraries. Our laboratory has recently emerged at the forefront of this nascent field due to the development of innovative Lab-on-Chip devices, one for the microinjection of Zebrafish embryos and another for the electrical micromanipulation of C.elegans worms. Building on our recent successes, the short-term aim of our research program, is to investigate and understand the fundamental science behind interaction of mechanical and electric forces with biological living organisms and use it to design innovative Lab-on-Chip devices. Additional aims include developing hybrid micro and nanofabrication technologies for their manufacture and to investigate electrically controlled micro and nanofluidic technologies for controlling the transport, positioning and injection into these organisms. Over the long term, we will develop integrated microsystems that are capable of performing specific bioanalysis on cells, embryos or worms in a low-cost, high-throughput and accurate manner and customize it towards specific applications in drug discovery or in other biological studies. By lowering the cost of research and enhancing capability and speed, these systems can significantly enhance discovery of new drugs and understanding of biological processes.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
327592-2010
Name nom
Selvaganapathy, Ponnambalam
Department département
Mechanical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2010
Award amount
43000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1510
Committee name en
Electrical and Computer Engineering
Committee name fr
Génie électrique et informatique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
2
Nb partie
5
Application title
Microsystems for drug discovery and biological studies
Keyword
NSERC
Application summary
Microfabricated Lab-on-Chip devices for genomics and proteomics have been widely researched and developed over the past decade and have gained significant acceptance among biological and biomedical researchers. The next grand challenge is the miniaturization of laboratory automation technologies for handling and manipulating living biological cells, embryos and small organisms that would enable faster analysis, lower cost, greater precision and parallelization (high throughput) over existing methods. These devices are essential in many biological studies and procedures such as embryology, in-vitro fertilization, transgenics, stem cell engineering/ transformation and in toxicology. They are also critically important in the drug discovery process where increasingly, small model organisms such as Zebrafish and C.elegans are being used for determining potent drug candidates from millions of molecules in the chemical compound libraries. Our laboratory has recently emerged at the forefront of this nascent field due to the development of innovative Lab-on-Chip devices, one for the microinjection of Zebrafish embryos and another for the electrical micromanipulation of C.elegans worms. Building on our recent successes, the short-term aim of our research program, is to investigate and understand the fundamental science behind interaction of mechanical and electric forces with biological living organisms and use it to design innovative Lab-on-Chip devices. Additional aims include developing hybrid micro and nanofabrication technologies for their manufacture and to investigate electrically controlled micro and nanofluidic technologies for controlling the transport, positioning and injection into these organisms. Over the long term, we will develop integrated microsystems that are capable of performing specific bioanalysis on cells, embryos or worms in a low-cost, high-throughput and accurate manner and customize it towards specific applications in drug discovery or in other biological studies. By lowering the cost of research and enhancing capability and speed, these systems can significantly enhance discovery of new drugs and understanding of biological processes.